DiaMedica Therapeutics Inc
DMAC
Get informed when a big investor buys or sells
+ FollowMarket Cap$344.31M
Close$
$0.33
95% downside
Current Fair Value
95% downsideOvervalued by 95% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $344.31 Million |
|---|---|
| Enterprise Value | $339.37 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.7 |
| Beta | 0.97 |
| Outstanding Shares | 53,894,295 |
Return
| Return on Equity | -97.92% |
|---|---|
| Return on Assets | -83.42% |
| Return on Invested Capital | -73.89% |
Valuation & Multiples
| P/E Ratio | -8.88 |
|---|---|
| PEG | -28 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.96 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationNext Earnings Call
Expected Date
November 11, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$13.50 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 74.32% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 23.37%▲ 1.62% |
|---|---|
| Total Invested | $88.97M▲ 12.38% |
| Investors Holding | 91▼ 11.00% |
ESG Score
No data